25682-025Level 3
Ultomiris (ravulizumab)
**Product type:** Human Prescription Drug
**Active ingredient:** RAVULIZUMAB
**Strength:** 300 mg/3mL
**Dosage form:** Solution, Concentrate
**Route:** Intravenous
**Labeler:** Alexion Pharmaceuticals Inc.
**Marketing category:** BLA (BLA761108)
**Pharmacologic class:** Complement Inhibitor [EPC], Complement Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/25682-025Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.